Literature DB >> 20498611

Quantitative computed tomography liver perfusion imaging using dynamic spiral scanning with variable pitch: feasibility and initial results in patients with cancer metastases.

Robert Goetti1, Sebastian Leschka, Lotus Desbiolles, Ernst Klotz, Panagiotis Samaras, Lotta von Boehmer, Frank Stenner, Cäcilia Reiner, Paul Stolzmann, Hans Scheffel, Alexander Knuth, Borut Marincek, Hatem Alkadhi.   

Abstract

PURPOSE: To assess the feasibility and image quality of computed tomography (CT) liver perfusion imaging using an adaptive 4D spiral-mode, developed to extend the z-axis coverage, and to report initial qualitative and quantitative results in patients with cancer metastases.
MATERIALS AND METHODS: A total of 21 patients with liver metastases of various origins underwent CT perfusion imaging (100 kV and 150 mAs/rot) using a 4D spiral-mode with single-source 64-slice CT (n = 7) with a scan range of 6.7 cm (protocol A: 16 cycles, 46.5 seconds examination time), or dual-source 128-slice CT with a scan range of 14.8 cm (protocol B: 16 cycles, 46.5 seconds examination time, n = 7; protocol C: 12 cycles, 51.0 seconds examination time, n = 7). Ability to suspend respiration during perfusion imaging was monitored. Two independent readers assessed image quality on a 4-point scale, both before and after motion correction, and performed a qualitative (ie, arterial enhancement pattern and enhancement change over time) and quantitative perfusion (ie, arterial liver perfusion [ALP]; portal-venous perfusion [PVP]; hepatic perfusion index [HPI]) analysis.
RESULTS: Of 21 patients, 7 (33%) could suspend respiration throughout the perfusion study and 14 (67%) resumed shallow breathing during the perfusion scan. The 21 patients had a total of 88 metastases. The scan range of protocol A covered at least 1 metastasis in all patients (total 20/34 [58.8%] metastases). The scan range of protocol B and C covered 53 of 54 (98.1%) metastases, whereas one metastasis in segment VIII was only partially imaged. Image quality was diagnostic both before and after motion correction, whereas being significantly better after motion correction (P < 0.001). Qualitative perfusion analysis of 67 metastases revealed diffuse arterial enhancement in 3 (4.5%), sparse enhancement in 11 (16.4%), peripheral-nodular enhancement in 9 (13.4%), rim-like enhancement in 15 (22.4%), and none in 29 (43.3%) metastases. Enhancement over time of 67 metastases showed a centripetal progression in 6 (8.9%), sustained portal phase in 16 (23.9%), wash-out in 16 (23.9%), and none in 29 (43.3%) metastases. Quantitative perfusion analysis revealed significantly higher arterial liver perfusion and HPI in metastases and metastasis borders than in adjacent normal liver tissue (P < 0.001 each). Portal-venous perfusion was significantly lower in metastases and metastasis borders than in normal liver tissue (P < 0.001). There were no significant differences in image quality and qualitative perfusion analysis between the 3 protocols (P = n.s.). Calculated effective radiation doses were 13.4 mSv for protocol A, 30.7 mSv for protocol B, and 23.0 mSv for protocol C.
CONCLUSION: CT perfusion imaging of the liver using the 4D spiral-mode is feasible with diagnostic image quality, and enables the reliable qualitative and quantitative analysis of the normal and metastatic liver parenchyma. Radiation dose issues must be considered when determining the scan range, number of cycles, and scan duration of the perfusion CT protocol.

Entities:  

Mesh:

Year:  2010        PMID: 20498611     DOI: 10.1097/RLI.0b013e3181e1937b

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  17 in total

1.  Radiation dose from volumetric helical perfusion CT of the thorax, abdomen or pelvis.

Authors:  Vicky Goh; Minaxi Dattani; Joseph Farwell; Jane Shekhdar; Emily Tam; Shilpan Patel; Jaspal Juttla; Ian Simcock; James Stirling; Henry Mandeville; Edwin Aird; P Hoskin
Journal:  Eur Radiol       Date:  2010-11-18       Impact factor: 5.315

2.  Time-resolved computed tomography of the liver: retrospective, multi-phase image reconstruction derived from volumetric perfusion imaging.

Authors:  Michael A Fischer; Bertil Leidner; Nikolaos Kartalis; Anders Svensson; Peter Aspelin; Nils Albiin; Torkel B Brismar
Journal:  Eur Radiol       Date:  2013-08-31       Impact factor: 5.315

3.  Perfusion computed tomography for detection of hepatocellular carcinoma in patients with liver cirrhosis.

Authors:  Michael A Fischer; Nikolaos Kartalis; Aristeidis Grigoriadis; Louiza Loizou; Per Stål; Bertil Leidner; Peter Aspelin; Torkel B Brismar
Journal:  Eur Radiol       Date:  2015-04-23       Impact factor: 5.315

4.  Renal versus splenic maximum slope based perfusion CT modelling in patients with portal-hypertension.

Authors:  Michael A Fischer; Katharina Brehmer; Anders Svensson; Peter Aspelin; Torkel B Brismar
Journal:  Eur Radiol       Date:  2016-02-25       Impact factor: 5.315

5.  Nonconvex prior image constrained compressed sensing (NCPICCS): theory and simulations on perfusion CT.

Authors:  J C Ramirez-Giraldo; J Trzasko; S Leng; L Yu; A Manduca; C H McCollough
Journal:  Med Phys       Date:  2011-04       Impact factor: 4.071

6.  Porcine ex vivo liver phantom for dynamic contrast-enhanced computed tomography: development and initial results.

Authors:  Scott M Thompson; Juan C Ramirez-Giraldo; Bruce Knudsen; Joseph P Grande; Jodie A Christner; Man Xu; David A Woodrum; Cynthia H McCollough; Matthew R Callstrom
Journal:  Invest Radiol       Date:  2011-09       Impact factor: 6.016

7.  Perfusion CT best predicts outcome after radioembolization of liver metastases: a comparison of radionuclide and CT imaging techniques.

Authors:  Fabian Morsbach; Bert-Ram Sah; Lea Spring; Gilbert Puippe; Sonja Gordic; Burkhardt Seifert; Niklaus Schaefer; Thomas Pfammatter; Hatem Alkadhi; Caecilia S Reiner
Journal:  Eur Radiol       Date:  2014-05-12       Impact factor: 5.315

8.  Reproducibility and variability of very low dose hepatic perfusion CT in metastatic liver disease.

Authors:  Osman Melih Topcuoğlu; Muşturay Karçaaltıncaba; Deniz Akata; Mustafa Nasuh Özmen
Journal:  Diagn Interv Radiol       Date:  2016 Nov-Dec       Impact factor: 2.630

9.  [Perfusion computed tomography for diffuse liver diseases].

Authors:  S A Schmidt; M S Juchems
Journal:  Radiologe       Date:  2012-08       Impact factor: 0.635

10.  Arterio-portal shunts in the cirrhotic liver: perfusion computed tomography for distinction of arterialized pseudolesions from hepatocellular carcinoma.

Authors:  Michael A Fischer; Herman P Marquez; Sonja Gordic; Bertil Leidner; Ernst Klotz; Peter Aspelin; Hatem Alkadhi; Torkel B Brismar
Journal:  Eur Radiol       Date:  2016-07-01       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.